NASDAQ: ETNB

Company Deals

89bio Partners with BiBio Biopharma to Build API Facility for Pegozafermin in China

Fineline Cube Apr 15, 2024

U.S. biotechnology company 89bio (NASDAQ: ETNB) has secured the services of China-based Contract Development and...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer